Research Article

The Effect of Alcohol Consumption in Unresectable Hepatocellular Carcinoma with Transarterial Chemoembolization

Table 1

Baseline characteristics of patients before and after propensity score matching.

CharacteristicsBefore matchingAfter matching
Alcohol useAlcohol abstinence valueAlcohol useAlcohol abstinence value

Age (years)55.8 ± 8.856.4 ± 10.60.64055.7 ± 8.755.8 ± 10.80.953
AST35.2 ± 21.135.3 ± 21.80.98441.8 ± 30.540.4 ± 29.80.735
ALT52.2 ± 42.447.3 ± 34.90.56234.7 ± 20.636.5 ± 22.50.552
Bilirubin18.1 ± 10.217.6 ± 8.90.65018.4 ± 10.216.7 ± 8.70.209
Albumin35.3 ± 21.838.9 ± 5.00.21338.0 ± 6.838.6 ± 5.10.486
NLR2.5 ± 2.03.1 ± 3.00.3312.5 ± 2.12.8 ± 2.70.496
PLR106.7 ± 64.8121.9 ± 78.40.108107.3 ± 65.6107.7 ± 55.40.955
Max tumor size (cm)7.0 ± 3.86.4 ± 3.50.1567.1 ± 3.86.5 ± 3.70.298

Gender0.6180.788
Male921429091
Female91187

Smoking0.5340.881
Yes64916463
No37623435

HBV infection0.0810.534
Yes891228683
No12311215

HCV infection1.0000.718
Yes4735
No971469593

Cirrhosis0.2800.771
Yes621045957
No39493941

Ascites0.9800.809
Yes1018109
No911358889

TACE session0.0990.841
Once17151514
Multiple times841388384

Tumor number0.5120.436
135473227
≥2661066671

BCLC stage<0.0010.479
A3534
B561075663
C42413931

AFP level0.3580.881
<200631046364
≥20038493534

Child-Pugh0.083>0.999
A741267373
B27272525

ECOG score0.0140.275
0591125967
142413932